alantolactone has been researched along with Cancer of Mouth in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Z; Chen, S; Deng, Z; Ding, X; Huang, K; Li, J; Mao, Y; Ping, Y; Sun, X; Tu, C; Wu, G; Wu, T; Yang, B; Yang, Z; Zhang, Y; Zhao, Z; Zou, P | 1 |
1 other study(ies) available for alantolactone and Cancer of Mouth
Article | Year |
---|---|
Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells.
Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Down-Regulation; Dynamins; Humans; Mitochondria; Mouth Neoplasms; Phosphorylation; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2023 |